NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

BBNX

Beta Bionics Inc

Jul 11 • 04:00PM ET

12.67

Dollar change -0.89
Percentage change -6.56	%

Healthcare • Medical Devices • USA • NASD

Held by: VTI IWM VXF IWO VTWO SCHA IWN VTWG GINN SCHB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-	Insider Own	23.36%	Shs Outstand	43.35M	Perf Week	-6.29%
Market Cap	549.32M	Forward P/E	-	EPS next Y	-2.02	Insider Trans	11.26%	Shs Float	33.23M	Perf Month	-34.25%
Enterprise Value	324.82M	PEG	-	EPS next Q	-0.46	Inst Own	83.56%	Short Float	14.76%	Perf Quarter	7.28%
Income	-	P/S	-	EPS this Y	74.29%	Inst Trans	37.01%	Short Ratio	10.06	Perf Half Y	-
Sales	-	P/B	1.75	EPS next Y	8.49%	ROA	-	Short Interest	4.90M	Perf YTD	-46.38%
Book/sh	7.24	P/C	2.37	EPS next 5Y	38.94%	ROE	-	52W High	24.50 -48.29%	Perf Year	-
Cash/sh	5.34	P/FCF	-	EPS past 3/5Y	8.56% -	ROIC	-	52W Low	8.89 42.52%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	1807.41% -	Gross Margin	-	Volatility	6.19% 7.50%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	1.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	14.93	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	31.13	Recom	1.44
Dividend Gr. 3/5Y	- -	Current Ratio	15.88	EPS Q/Q	-50.30%	SMA20	-18.44%	Beta	-	Target Price	23.56
Payout	-	Debt/Eq	0.02	Sales Q/Q	111.25%	SMA50	-17.76%	Rel Volume	0.78	Prev Close	13.56
Employees	291	LT Debt/Eq	0.02	Earnings	Jul 29 AMC	SMA200	-19.76%	Avg Volume	487.41K	Price	12.67
IPO	Jan 30, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	-95.50% 9.23%	Trades		Volume	379,780	Change	-6.56%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	Truist	Buy	$26
Jun-12-25	Initiated	Lake Street	Buy	$30
May-30-25	Initiated	Wolfe Research	Outperform	$20
May-30-25	Initiated	Goldman	Neutral	$16
Feb-24-25	Initiated	Stifel	Buy	$25
Feb-24-25	Initiated	Piper Sandler	Overweight	$26
Feb-24-25	Initiated	Leerink Partners	Outperform	$28
Feb-24-25	Initiated	Lake Street	Buy	$30
Feb-24-25	Initiated	BofA Securities	Buy
Feb-20-25	Initiated	Robert W. Baird	Neutral	$20
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral	$20

Show Previous Ratings

Jul-04-25 02:43AM	Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas (Insider Monkey)
Jul-02-25 07:30AM	Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 (GlobeNewswire)
Jun-24-25 03:59PM	Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions (GlobeNewswire)
06:56AM	ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors (MedTech Dive)
Jun-23-25 11:20AM	BBNX Stock May Gain From Abbott Deal to Advance iLet Integration (Zacks) -11.68%
07:06AM	Loading…
Jun-20-25 07:06AM	5 things to watch at the ADAs Scientific Sessions (MedTech Dive)
Jun-19-25 07:00AM	Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor (GlobeNewswire)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-02-25 05:01AM	Beta Bionics CEO, CFO on how to take a company public (MedTech Dive) +8.41%
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive) +6.44%
May-07-25 03:22AM	Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +26.61%
May-06-25 04:02PM	Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 (GlobeNewswire)
May-01-25 08:00AM	Beta Bionics to Present at the Bank of America Securities Health Care Conference (GlobeNewswire)
Apr-24-25 11:44AM	Beta Bionics: Slowing Down Or Being Conservative? (Seeking Alpha) +5.74%
Apr-19-25 05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
04:05PM	Loading…
Apr-16-25 04:05PM	Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-09-25 07:30AM	Beta Bionics to Host Investor Event on June 22, 2025 (GlobeNewswire) +21.63%
Mar-28-25 06:00AM	Newly public Beta Bionics reports sales surge; Dexcom hires CCO (MedTech Dive) -7.58%
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
Mar-25-25 04:02PM	Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 (GlobeNewswire) -13.60%
Mar-03-25 12:59PM	Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-27-25 07:00AM	Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 (GlobeNewswire)
Feb-21-25 09:35AM	Palantir initiated, Roku upgraded: Wall Streets top analyst calls (TipRanks)
Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sean Saint	Officer	Jun 02 '25	Proposed Sale	17.89	3,439	61,524		Jun 09 08:30 PM
Hopman Mark	Chief Commercial Officer	Jun 02 '25	Sale	17.89	868	15,529	34,132	Jun 04 07:30 PM
Russell Steven Jon	Chief Medical Officer	Jun 02 '25	Sale	17.89	1,039	18,588	72,032	Jun 04 07:30 PM
Mensinger Mike	Chief Product Officer	Jun 02 '25	Sale	17.89	1,115	19,948	92,904	Jun 04 07:30 PM
Feider Stephen	Chief Financial Officer	Jun 02 '25	Sale	17.89	1,497	26,783	45,503	Jun 04 07:30 PM
Saint Sean	President & CEO	Jun 02 '25	Sale	17.89	3,439	61,526	104,561	Jun 04 07:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Buy	17.00	33,350	566,950	59,019	Feb 03 08:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Sale	17.00	13	221	25,669	Feb 03 08:30 PM
Wellington Hadley Harbor Aggre	10% Owner	Jan 31 '25	Buy	17.00	1,000,000	17,000,000	3,901,599	Feb 03 04:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your FINVIZ experience